OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming
Chen Hu, Dongde Wu, Lequn Bao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 1353-1358
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives
María Paula Ceballos, Ariel D. Quiroga, Nicolás Francisco Palma
Biochemical Pharmacology (2023) Vol. 212, pp. 115573-115573
Closed Access | Times Cited: 6

Deciphering the Role of Mitochondrial DNA Targeted Therapy in Hepatic Cell Carcinoma
Madhunika Agrawal, Satyam Kumar Agrawal
Gene Expression (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2

CTAB Enhances Chemo-Sensitivity Through Activation of AMPK Signaling Cascades in Breast Cancer
Yue Pan, Yunqiu Zhang, Qing Chen, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 16

Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
Jiali Xu, Guosheng Ren, Qiao Cheng
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 5

The effects of fructose and metabolic inhibition on hepatocellular carcinoma
Brittany Dewdney, Mohammed H. Alanazy, Rhys Gillman, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 14

6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming
Jun Cao, Xiaosong Sun, Xuejun Zhang, et al.
The American Journal of the Medical Sciences (2020) Vol. 360, Iss. 3, pp. 279-286
Closed Access | Times Cited: 12

Are we still on the right path(way)?: the altered expression of the pentose phosphate pathway in solid tumors and the potential of its inhibition in combination therapy
Caroline J. W. Meskers, Marika Frańczak, Ryszard T. Smoleński, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 1, pp. 61-83
Closed Access | Times Cited: 8

Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation
Rui Qiao, Mengmeng Wei, Hui Chen, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 8, pp. 825-835
Open Access | Times Cited: 3

Identification of Lignan Compounds as New 6-Phosphogluconate Dehydrogenase Inhibitors for Lung Cancer
Gul Bushra Khan, Muhammad Qasim, Azhar Rasul, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 34-34
Open Access | Times Cited: 5

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
Tiantian Liu, Jianni Qi, Hao Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4

Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
Hongyu Chen, Xiaoqin Lai, Yihan Zhu, et al.
Clinical Proteomics (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 3

Physcion Enhances Sensitivity of Pancreatic Adenocarcinoma and Lung Carcinoma Cell Lines to Cisplatin
Daria Savenkova, K.V. Havrysh, V. Skripova, et al.
BioNanoScience (2020) Vol. 10, Iss. 3, pp. 549-553
Closed Access | Times Cited: 3

Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?
Weili Wang, Rong Dai, Meng Cheng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access

A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer
Ariel Shimoni-Sebag, Ifat Abramovich, Bella Agranovich, et al.
Radiotherapy and Oncology (2024) Vol. 202, pp. 110606-110606
Closed Access

Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA
Camilla Olaisen, Lisa Marie Røst, Animesh Sharma, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3963-3963
Open Access

Research Progress on the Anti-Liver Cancer Mechanism and Toxicity of Rhubarb Anthraquinone
Linyuan Yu, Jiwei Qin, Mei Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6089-6113
Open Access

Cancer metabolism regulation by phytonutrients
Ammara Riaz, Rabia Zara, Gul Bushra, et al.
Elsevier eBooks (2022), pp. 237-290
Closed Access | Times Cited: 1

Hyperosmolar Potassium Inhibits Corneal Myofibroblast Transformation and Prevent Corneal Scar
Kai Liao, Zekai Cui, Zhijie Wang, et al.
Current Eye Research (2022) Vol. 48, Iss. 3, pp. 238-250
Open Access | Times Cited: 1

Pentose Phosphate Pathway Inhibition activates Macrophages towards phagocytic Lymphoma Cell Clearance
Anna C. Beielstein, Elena Izquierdo, Stuart J. Blakemore, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Analysis of the Inhibitory Effect of hsa-miR-145-5p and hsa-miR-203a-5p on Imatinib-Resistant K562 Cells by GC/MS Metabolomics Method
Priyanka Singh, Radheshyam Yadav, Malkhey Verma, et al.
Journal of the American Society for Mass Spectrometry (2023) Vol. 34, Iss. 10, pp. 2117-2126
Closed Access

The in vitro effect of 5-FU and Tamoxifen Chemotherapeutics on penthose phosphate pathway enzymes
Yusuf Temel
Cumhuriyet Science Journal (2021) Vol. 42, Iss. 2, pp. 245-251
Open Access

Previous Page - Page 2

Scroll to top